DUSP2 and allergic disease: This finding suggested that PAC1 might serve as a constraining factor limiting the capacity of ILC2s to drive type 2 inflammation in clinical allergic disease, initially supporting the idea that PAC1 may be involved in regulating ILC2 responses.